Metabolic and bariatric surgery: diabetes - a decade of discovery

References

[1] US Centers for Disease Control and Prevention. Diabetes statistics. Available from: https://www.cdc.gov/chronicdisease/resources/publications/aag/diabetes.htm [Last accessed on 17 Jan 2020]

[2] International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation, 2019. Available from: http://www.diabetesatlas.org [Last accessed on 17 Jan 2020]

[3] World Health Organization - Diabetes. Available from: https://www.who.int/health-topics/diabetes [Last accessed on 17 Jan 2020]

[4] Dixon JB,Alberti KG.Bariatric surgery: an IDF statement for obese Type 2 diabetes..Surg Obes Relat Dis2011;7:433-47 PMCID:PMC3123702

[5] Reusch JE.Management of type 2 diabetes in 2017: getting to goal..JAMA2017;317:1015-6 PMCID:PMC5894353

[6] Schauer PR,Kirwan JP,Aminian A.Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes..N Engl J Med2017;376:641-51 PMCID:PMC5451258

[7] Mingrone G,De Gaetano A,Iaconelli A.Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial..Lancet2015;386:964-73

[8] Brito JP,Davis AM.Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations..JAMA2017;317:635-6 PMCID:PMC5557277

[9] Rubino F,Eckel RH,Alberti KGMM.Metabolic surgery in the treatment algorithm for type 2 diabetes..Diabetes Care2016;39:861-877

[10] Aminian A.Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy..Surg Obes Relat Dis2020;Epub ahead of print [DOI: https://doi.org/10.1016/j.soard.2019.11.013]

[11] Arterburn DE,Sherwood NE,Coleman KJ.A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass..Obes Surg2013;23:93-102 PMCID:PMC4641311

[12] de Oliveira VLP,Mottin CC,Friedman R.Predictors of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass in severely obese patients..Obes Surg2018;28:195-203

[13] Viscido G,Signorini FJ,Navarro L.Obese patients with type 2 diabetes: outcomes after laparoscopic sleeve gastrectomy..J Laparoendosc Adv Surg Tech A2019;29:655-62

[14] Sánchez-Pernaute A,Cabrerizo L,Torres A.Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients..Surg Obes Relat Dis2015;11:1092-8

[15] Salminen P,Ovaska J,Leivonen M.Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial..JAMA2018;319:241-54 PMCID:PMC5833550

[16] Peterli R,Peters T,Kröll D.Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial..JAMA2018;319:255-65 PMCID:PMC5833546

[17] Ruiz-Tovar J,Jimenez JM,Gonzalez G.Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities..Surg Endosc2019;33:401-10

[18] Hofsø D,Borgeraas H,Gulseth HL.Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial..Lancet Diabetes Endocrinol2019;7:912-24

[19] Aminian A,Andalib A,Jimenez A.Individualized metabolic surgery score: procedure selection based on diabetes severity..Ann Surg2017;266:650-7

[20] Haskins IN,Froylich D,Hag A.Primary inadequate weight loss after roux-en-y gastric bypass is not associated with poor cardiovascular or metabolic outcomes: experience from a single institution..Obes Surg2017;27:676-80

[21] Aminian A,Andalib A,Mackey J.Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes..Ann Surg2016;264:674-81

[22] Aleassa EM,Hayes K,Schauer PR.Effect of revisional bariatric surgery on type 2 diabetes mellitus..Surg Endosc2019;33:2642-8

[23] Yan J,Aminian A.Reoperative bariatric surgery for treatment of type 2 diabetes mellitus..Surg Obes Relat Dis2017;13:1412-21

[24] Dardamanis D,Coubeau L.A retrospective comparative study of primary versus revisional Roux-en-Y gastric bypass: long-term results..Obes Surg2018;28:2457-64

[25] Dijkhorst PJ,Janssen IMC,Wiezer RMJ.Failed sleeve gastrectomy: single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass? A multicenter cohort study..Obes Surg2018;28:3834-42 PMCID:PMC6223754

[26] Casillas RA,Zelada Getty JL,Kim BB.Revision of primary sleeve gastrectomy to Roux-en-Y gastric bypass: indications and outcomes from a high-volume center..Surg Obes Relat Dis2016;12:1817-25

[27] Hutch CR.The role of GLP-1 in the metabolic success of bariatric surgery..Endocrinology2017;158:4139-51 PMCID:PMC5711387

[28] Aminian A,Arterburn DE,Brethauer SA.Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity..JAMA2019;322:1271-82 PMCID:PMC6724187